Eli Lilly lifts sales view by $2 billion on soaring weight-loss drug demand
Lilly said it expects the drugs to remain in tight supply, but plans for significant production increases in the second half of the year.
If you are not happy with the results below please do another search
Lilly said it expects the drugs to remain in tight supply, but plans for significant production increases in the second half of the year.
Based on strong overall and progression-free survival data in its Phase III confirmatory study, Pfizer and Genmab’s antibody-drug conjugate Tivdak on Monday secured the FDA’s full approval for recurrent or metastatic cervical cancer that had progressed on or after chemotherapy.
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu significantly improved progression-free survival in metastatic breast patients with low and ultralow HER2 expression levels who had received at least one line of systemic treatment.
Ono Pharmaceutical said Monday it will pay $2.4 billion to acquire Deciphera Pharmaceuticals for cancer drugs that could generate peak annual sales of more than $1 billion.
IRIS offers immersive insights reports and live dashboards designed to help the healthcare industry and other stakeholders anticipate and identify transformative market events, and how best to strategically navigate the fast-moving environment.
2023 was definitely a busy year for many agencies as the world continued to move on from the pandemic. Despite economic headwinds, several of the agencies featured in this issue reported growth and an increase in the number of their clients and accounts held. The other commonality noted in these profiles was an unhesitating attitude towards the adoption of generative and analytical AI tools for themselves and their clients, leading to new opportunities.
“Ken embodies the essence of leadership, not just through his actions but through his unwavering commitment to do better … to be better. Ken embodies a culture of continuous learning and development, encouraging each member of our team to reach their full potential.”
Sarah Hansen is associate director, US Patient Marketing Metabolics, Alexion. She was nominated by Snow Companies.
To qualify for this annual report, agencies must have the capabilities to develop marketing strategies that target healthcare professionals (physicians, nurse practitioners, nurses, pharmacists, etc.), and/or consumers, and/or patients, and/or stakeholders such as managed market payers. Marketing strategies include the capability to create and place advertisements
2023 was a high velocity year for AbelsonTaylor Group. Reflecting its successful expansion into new areas of healthcare marketing, the company announced its formation of an independent network containing three business units: flagship agency AbelsonTaylor, opportunity agency AT Nutrient, and full-service production studio DOSE.